DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga·07/24/2025 17:06:06
Listen to the news

Gainers

  • Healthcare Triangle (NASDAQ:HCTI) stock rose 74.6% to $0.04 during Thursday's regular session. The market value of their outstanding shares is at $10.2 million.
  • Plus Therapeutics (NASDAQ:PSTV) stock moved upwards by 41.51% to $0.69. The company's market cap stands at $24.9 million.
  • X4 Pharmaceuticals (NASDAQ:XFOR) stock increased by 31.25% to $1.97. The company's market cap stands at $10.7 million.
  • Liminatus Pharma (NASDAQ:LIMN) stock increased by 30.6% to $8.45. The market value of their outstanding shares is at $170.5 million.
  • West Pharmaceutical Servs (NYSE:WST) shares increased by 20.77% to $274.53. The company's market cap stands at $16.3 billion. The company's, Q2 earnings came out today.
  • Sensus Healthcare (NASDAQ:SRTS) shares moved upwards by 19.49% to $5.64. The market value of their outstanding shares is at $77.6 million.

Losers

  • Community Health Sys (NYSE:CYH) stock decreased by 27.6% to $2.81 during Thursday's regular session. The market value of their outstanding shares is at $544.3 million. As per the press release, Q2 earnings came out yesterday.
  • Polyrizon (NASDAQ:PLRZ) stock decreased by 19.15% to $1.52. The market value of their outstanding shares is at $10.0 million.
  • Sarepta Therapeutics (NASDAQ:SRPT) shares fell 18.51% to $10.86. The company's market cap stands at $1.3 billion.
  • NovoCure (NASDAQ:NVCR) stock declined by 16.84% to $13.73. The company's market cap stands at $1.8 billion. As per the press release, Q2 earnings came out today.
  • Iovance Biotherapeutics (NASDAQ:IOVA) stock decreased by 15.24% to $3.37. The market value of their outstanding shares is at $1.3 billion.
  • Apollomics (NASDAQ:APLM) shares fell 14.41% to $5.11. The market value of their outstanding shares is at $6.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.